Post Market Surveillance (PMS) refers to the process of monitoring the safety and effectiveness of medical devices and pharmaceuticals after they have been released on the market. This is particularly important in gynecology, where devices and treatments can have significant impacts on women's health. PMS involves collecting data on adverse events, device performance, and patient outcomes.
